Pashtoon Kasi/LinkedIn
Apr 1, 2025, 16:32
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers
Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, shared an article by Frank J. Lowery, et al. on X:
“Today!
TILs Tumor Infiltrating Lymphocytes – a cell-based therapy for patients with colorectal and GI cancers.
Responses plus “survivors” – black arrows. Four >48-month survival approximately CURES.
Pembro increases responses.
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial
Authors: Frank J. Lowery, Stephanie L. Goff, Steven A. Rosenberg et al.
More posts featuring Pashtoon Kasi.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 23, 2025, 08:18
Apr 23, 2025, 08:09
Apr 23, 2025, 07:49
Apr 23, 2025, 07:21
Apr 23, 2025, 06:49
Apr 23, 2025, 06:34